Luvesilocin (RE104)
Postpartum Depression (PPD)
Key Facts
About Reunion Neuroscience
Reunion Neuroscience is a venture-backed, clinical-stage biotech company pioneering next-generation psychedelic-based mental health therapies. Its lead candidate, luvesilocin (RE104), a short-duration prodrug of a psilocybin-like compound, has received FDA Breakthrough Therapy Designation for postpartum depression following positive Phase 2 results. The company is targeting significant unmet needs in psychiatry with a pipeline focused on rapid-onset, durable antidepressant effects, leveraging a team with deep neuroscience drug development expertise.
View full company profileAbout Reunion Neuroscience
Reunion Neuroscience is a venture-backed, clinical-stage biotech company pioneering next-generation psychedelic-based mental health therapies. Its lead candidate, luvesilocin (RE104), a short-duration prodrug of a psilocybin-like compound, has received FDA Breakthrough Therapy Designation for postpartum depression following positive Phase 2 results. The company is targeting significant unmet needs in psychiatry with a pipeline focused on rapid-onset, durable antidepressant effects, leveraging a team with deep neuroscience drug development expertise.
View full company profileAbout Reunion Neuroscience
Reunion Neuroscience is a venture-backed, clinical-stage biotech company pioneering next-generation psychedelic-based mental health therapies. Its lead candidate, luvesilocin (RE104), a short-duration prodrug of a psilocybin-like compound, has received FDA Breakthrough Therapy Designation for postpartum depression following positive Phase 2 results. The company is targeting significant unmet needs in psychiatry with a pipeline focused on rapid-onset, durable antidepressant effects, leveraging a team with deep neuroscience drug development expertise.
View full company profileTherapeutic Areas
Other Postpartum Depression (PPD) Drugs
| Drug | Company | Phase |
|---|---|---|
| GH001 | GH Research | Phase 2a |
| LPCN 1154 | Lipocine | Phase 3 |